ORKA

Oruka Therapeutics Stock Analysis

AI Rating

Good
  • Quality5/10
  • Growth↓ 4/10
  • Value↑ 6/10
Oruka Therapeutics sales and earnings growth
ORKA Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 52.20%
  • FCF Y/Y↓ -52.38%
Oruka Therapeutics gross and profit margin trends
ORKA Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ 0.00%
Oruka Therapeutics net debt vs free cash flow
ORKA Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Oruka Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗